Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 22c
Tweet
Share
E-mailGet Alerts FLGT Hot Sheet
Join SI Premium – FREE
Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of $0.16, $0.22 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $83.3 million versus the consensus estimate of $84.5 million.
For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
